Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Effect of combination therapy of hydroxyurea with l-carnitine and magnesium chloride on hematologic parameters and cardiac function of patients with beta-thalassemia intermedia
European Journal of Haematology, 11/04/09
Karimi M et al. – Combination of hydroxyurea with l–carnitine or magnesium could be more effective in improving hematologic parameters and cardiac status in patients with beta–thalassemia intermedia than hydroxyurea alone.
Related Articles
Beta-Thalassemia in the Korean population
International Journal of Hematology, 10/12/09
Relevance Score: 68%
Predictors of Physical and Mental Health-Related Quality of Life in Beta Thalassemia
Journal of Research in Medical Sciences, 11/02/09
Relevance Score: 67%
Glutathione S-transferase gene deletions and their effect on iron status in HbE/beta thalassemia patients
Annals of Hematology, 10/23/09
Relevance Score: 67%
Pregnancy and beta-thalassemia: an Italian multicenter experience
Haematologica, 11/16/09
Relevance Score: 66%
Carrier screening and genetic counselling in beta-thalassemia
International Journal of Hematology, 10/12/09
Relevance Score: 66%
Today in Anemia/Polycythemia...keeping you current
Receive free subspecialty "5-minute updates" via email
Peripheral arterial tonometry in assessing endothelial dysfunction in pediatric sickle cell disease
Pediatric Hematology and Oncology, 11/25/09
Hydroxyurea-induced hematological response in transfusion-independent beta-thalassemia intermedia: case series and review of literature
Pediatric Hematology and Oncology, 11/25/09
Src tyrosine kinase pre-activation is associated with platelet hypersensitivity in essential thrombocythemia and polycythemia vera
Blood, 11/25/09
Today in Pediatric Heme/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Peripheral arterial tonometry in assessing endothelial dysfunction in pediatric sickle cell disease
Pediatric Hematology and Oncology, 11/25/09
Hepatoblastoma metastatic to the right atrium responding to chemotherapy alone
Pediatric Hematology and Oncology, 11/25/09
Association between defb1 gene haplotype and herpes viruses seroprevalence in children with acute lymphoblastic leukemia
Pediatric Hematology and Oncology, 11/25/09
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Sorafenib, a dual Raf kinase/vascular endothelial growth factor receptor inhibitor has significant anti-myeloma activity and synergizes with common anti-myeloma drugs
Oncogene, 11/25/09
Pharmacogenetics of telatinib, a VEGFR-2 and VEGFR-3 tyrosine kinase inhibitor, used in patients with solid tumors
Investigational New Drugs, 11/25/09
Adding more content to screening: reactivation of FOXO as a therapeutic strategy
Clinical and Translational Oncology, 11/25/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


